The China Mail - US vaccine panel upends hepatitis B advice in latest Trump-era shift

USD -
AED 3.673037
AFN 63.999892
ALL 80.977186
AMD 362.830155
ANG 1.790365
AOA 917.999844
ARS 1524.953906
AUD 1.439263
AWG 1.8025
AZN 1.698534
BAM 1.722428
BBD 2.015086
BDT 123.012972
BGN 1.683441
BHD 0.376952
BIF 2995
BMD 1
BND 1.277405
BOB 12.040458
BRL 5.1786
BSD 1.000454
BTN 95.892522
BWP 14.09417
BYN 3.010995
BYR 19600
BZD 2.012171
CAD 1.42275
CDF 2309.999448
CHF 0.83523
CLF 0.024658
CLP 973.639829
CNY 6.70475
CNH 6.709005
COP 3314.43
CRC 456.985341
CUC 1
CUP 24.01166
CVE 97.750022
CZK 21.56055
DJF 177.719792
DKK 6.597021
DOP 55.980195
DZD 133.838825
EGP 51.939199
ERN 15
ETB 163.421342
EUR 0.882515
FJD 2.24625
FKP 0.756991
GBP 0.75375
GEL 2.604982
GGP 0.756991
GHS 11.694587
GIP 0.756991
GMD 73.504454
GNF 8798.844552
GTQ 7.643396
GYD 209.328131
HKD 7.8476
HNL 26.859007
HRK 6.649602
HTG 130.939066
HUF 323.429923
IDR 18336.7
ILS 3.07365
IMP 0.756991
INR 95.94315
IQD 1310.606294
IRR 1693792.50032
ISK 120.899758
JEP 0.756991
JMD 158.336929
JOD 0.709015
JPY 157.383971
KES 129.739459
KGS 87.448702
KHR 4057.22564
KMF 434.999706
KPW 900.000318
KRW 1357.87998
KWD 0.308899
KYD 0.833726
KZT 440.074329
LAK 22455.503791
LBP 89592.031739
LKR 330.60617
LRD 171.583824
LSL 16.385613
LTL 2.95274
LVL 0.60489
LYD 6.399
MAD 9.712993
MDL 17.763022
MGA 4394.578552
MKD 54.223526
MMK 2099.600314
MNT 3599.1704
MOP 8.086624
MRU 40.069045
MUR 47.701561
MVR 15.45005
MWK 1734.754084
MXN 18.068165
MYR 4.080503
MZN 63.910056
NAD 16.385685
NGN 1327.689877
NIO 36.821108
NOK 9.487685
NPR 153.428035
NZD 1.773855
OMR 0.38435
PAB 1.000449
PEN 3.44424
PGK 4.528402
PHP 62.715498
PKR 277.158584
PLN 3.85065
PYG 5852.979771
QAR 3.647324
RON 4.654798
RSD 103.721994
RUB 83.366336
RWF 1477.228194
SAR 3.755513
SBD 8.032647
SCR 13.871312
SDG 601.504398
SEK 10.010135
SGD 1.2764
SHP 0.755829
SLE 24.650172
SLL 20969.491881
SOS 571.727998
SRD 37.621497
STD 20697.981008
STN 21.576683
SVC 8.75393
SYP 13002.000254
SZL 16.377071
THB 33.580062
TJS 9.214436
TMT 3.51
TND 2.978703
TOP 2.40776
TRY 49.024415
TTD 6.787408
TWD 31.887102
TZS 2640.027998
UAH 44.690709
UGX 3921.672237
UYU 40.308767
UZS 11835.41907
VES 857.98905
VND 25962
VUV 119.008285
WST 2.76852
XAF 578.891892
XAG 0.016554
XAU 0.000240557805
XCD 2.70255
XCG 1.803098
XDR 0.707052
XOF 578.891892
XPF 105.029547
YER 236.403721
ZAR 16.41148
ZMK 9001.203741
ZMW 19.559579
ZWL 321.999592
SSP 5712.5919
MXV 2.045277
  • RYCEF

    0.4000

    19.71

    +2.03%

  • CMSC

    0.0000

    20.4

    0%

  • BTI

    0.4200

    56.05

    +0.75%

  • BP

    0.2800

    44.43

    +0.63%

  • RBGPF

    1.6000

    67

    +2.39%

  • RIO

    -0.1500

    94.41

    -0.16%

  • AZN

    -0.4300

    166.15

    -0.26%

  • GSK

    0.4600

    49.7

    +0.93%

  • BCE

    -0.4100

    20.56

    -1.99%

  • NGG

    -0.2500

    75.24

    -0.33%

  • VOD

    -0.0400

    16.58

    -0.24%

  • RELX

    -0.4500

    33.07

    -1.36%

  • BCC

    -0.5500

    76.59

    -0.72%

  • CMSD

    -0.0300

    20.27

    -0.15%

  • JRI

    -0.2500

    10.77

    -2.32%

US vaccine panel upends hepatitis B advice in latest Trump-era shift

US vaccine panel upends hepatitis B advice in latest Trump-era shift

An advisory panel appointed by the Trump administration's vaccine-skeptic health secretary voted Friday to stop recommending that all newborns in the United States receive a hepatitis B vaccine.

Text size:

The move to end the decades-old recommendation is the panel's latest contentious about-face on vaccine policy since its overhaul by Health Secretary Robert F. Kennedy Jr. earlier this year.

US health authorities previously recommended all babies, not just those born to mothers believed to have hepatitis B, receive the first of three vaccine doses just after birth.

The approach aimed, in part, to prevent transfers from mothers who unknowingly had hepatitis B or had falsely tested negative, and had virtually eradicated infections of the potentially deadly liver disease among young people in the country.

After delaying the vote by a day, the panel on Friday passed its new recommendation for "individual-based decision-making," in consultation with a health care provider, when children are born to mothers testing negatively for the disease.

The decision to vaccinate at birth should "consider vaccine benefits, vaccine risks, and infection risks."

The new recommendation was immediately condemned by several medical groups who noted widespread shortcomings in US maternal health screening as well as the possibility of infections from others.

"This irresponsible and purposely misleading guidance will lead to more hepatitis B infections in infants and children," American Academy of Pediatrics President Susan J. Kressly said in a statement.

The vote was 8-3. Trump-appointed officials at the Centers for Disease Control and Prevention (CDC) are expected to formally adopt the recommendations at a later date.

The panel also voted to recommend that babies who are not vaccinated at birth wait at least two months to get the initial dose, and that blood tests be done to measure antibodies before a second dose.

- Panel overhaul -

After becoming health secretary, Kennedy sacked every member of the once-staid Advisory Committee on Immunization Practices (ACIP), replacing them with figures whose vaccine-skeptic views track more closely with his own.

It has since set to work on reviewing prior recommendations -- already tweaking advice on Covid-19 and measles shots.

Medical experts fear the push could further contribute to declining vaccination rates in the United States.

The panel on Friday also began a broader review of the childhood vaccination schedule, and sparked further controversy by allowing testimony from lawyer Aaron Siri, a close Kennedy associate known for spreading unfounded theories on the subject.

While US President Donald Trump vocally supports Kennedy's policies, some in the Republican Party have pushed back, notably Louisiana Senator Bill Cassidy.

Medical doctor Cassidy condemned the ACIP decision on Friday, noting the original recommendation was never "a mandate" to get the jab.

CDC officials "should not sign these new recommendations and instead retain the current, evidence-based approach," he said on X.

Cassidy's expression of alarm, like his prior statements against Kennedy, provoked criticism after he provided the key vote to confirm the health secretary in February.

- 'Do no harm' -

The United States had urged universal vaccination at birth against hepatitis B since 1991, advice also recommended by China, Australia and the World Health Organization.

But several ACIP members argued Friday's decision would align the United States with other economically developed countries such as France and Britain.

The repercussions of the ACIP's vaccine recommendations are broad because federal guidelines often dictate whether vaccines are paid for by health insurance companies in the United States, where a vaccine can cost hundreds of dollars.

But the committee's influence is waning amid withering criticism from the US scientific and medical community, with Democratic-led states announcing they will no longer follow its recommendations.

Ahead of the vote, Dr. Cody Meissner, one of the few dissenting voices on the advisory committee, urged his colleagues not to change the current recommendations.

"Do no harm is a moral imperative. We are doing harm by changing this wording," he warned.

X.Gu--ThChM